Voyager Therapeutics (VYGR) Financials: Revenue & Earnings
$109.37M
Market Cap
-0.96
P/E
—
Forward P/E
46
Score
VYGR price $1.77 +0.04 +2.60%
Stocklytics score rationale: value 57, quality 30, growth 51.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 14220000 | 10135000 | 7619000 | 104391000 | 171128000 | 37415000 | 40907000 | 250008000 | 80001000 | 40374000 |
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis…
VYGR fair value $59.63. Price $1.77. Price is 97% below fair value.
Below fair value, and cheaper than usual. A larger discount than on 91% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 15.84M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 11.35% (beta 1.3). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 61.62M. Net debt -28.80M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.41 | — | 6.35M |
| 2026-08-06 | -0.40 | -0.48 | 3.17M | 4.52M |
| 2026-05-07 | -0.47 | -0.54 | 2.59M | 8.79M |
| 2026-03-09 | -0.46 | -0.54 | 15.34M | 10.49M |
| 2025-11-10 | -0.47 | -0.53 | 13.37M | 10.49M |
| 2025-08-06 | -0.57 | -0.48 | 5.20M | 7.86M |
| 2025-05-06 | -0.53 | -0.35 | 6.47M | 13.91M |
| 2025-03-11 | -0.59 | -0.35 | 6.28M | 12.95M |
| 2024-11-12 | -0.16 | -0.45 | 24.63M | 15.46M |
| 2024-08-06 | -0.18 | -0.38 | 29.58M | 9.46M |
| 2024-05-13 | -0.20 | -0.44 | 19.52M | 9.41M |
| 2024-02-28 | 1.25 | -0.29 | 90.06M | 20.63M |
| 2023-11-06 | -0.59 | -0.58 | 4.61M | 5.56M |
| 2023-08-03 | -0.51 | -0.59 | 4.85M | 1.77M |
| 2023-05-09 | 2.94 | 0.77 | 150.48M | 61.11M |
| 2023-03-07 | -0.61 | -0.57 | 41.09M | 4.19M |
| 2022-11-08 | 0.45 | -0.32 | 41.09M | 9.42M |
| 2022-08-04 | -0.50 | -0.56 | 712.00K | 7.03M |
| 2022-05-04 | -0.56 | -0.14 | 658.00K | 12.71M |
| 2022-03-08 | 0.15 | -0.32 | 28.07M | 4.30M |
| 2021-11-02 | -0.67 | -0.75 | 1.48M | 1.84M |
| 2021-08-09 | -0.80 | -0.75 | 1.36M | 1.36M |
| 2021-05-10 | -0.58 | -0.71 | 6.50M | 7.29M |
| 2021-02-25 | -0.43 | -0.52 | 6.54M | 8.05M |
| 2020-11-09 | 2.27 | -0.19 | 117.84M | 1.48B |
| 2020-08-10 | -0.23 | -0.75 | 28.68M | 89.78M |
| 2020-05-06 | -0.66 | -0.87 | 18.07M | 21.63M |
| 2020-03-03 | -0.34 | -0.81 | 32.67M | 77.84M |
| 2019-11-06 | -0.41 | -0.83 | 20.43M | 37.88M |
| 2019-08-09 | 0.29 | -0.75 | 46.09M | 119.19M |
| 2019-05-07 | -0.81 | -0.79 | 5.20M | 3.72M |
| 2019-02-26 | -0.70 | -0.66 | 2.01M | 2.01M |
| 2018-11-07 | -0.63 | -0.78 | 2.09M | 2.63M |
| 2018-08-07 | -0.80 | -0.63 | 2.58M | 2.16M |
| 2018-05-10 | -0.63 | -0.59 | 942.00K | 164.48K |
| 2018-03-14 | -0.40 | -0.72 | 6.34M | 11.42M |
| 2017-11-02 | -0.89 | -0.72 | 1.15M | 928.72K |
| 2017-08-08 | -0.73 | -0.62 | 1.18M | 984.36K |
| 2017-05-09 | -0.65 | -0.54 | 1.46M | 1.19M |
| 2017-03-15 | -0.57 | -0.45 | 2.36M | 1.91M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-09 | SCANGOS GEORGE A | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | MACKEY CATHERINE J | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | Hyman Steven | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | Vitale Nancy | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | Higgins Michael J | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | Onyia Jude | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | GERAGHTY JAMES A | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | Colon Grace | Buy | 30.00K | $3.43 | 102.90K |
| 2026-06-09 | PIERCE GLENN | Buy | 30.00K | $3.43 | 102.90K |
| 2026-05-08 | Quinlan Amy | Other | 0 | — | — |
| 2026-05-08 | Quinlan Amy | Other | 50.00K | $5.28 | 264.00K |
| 2026-05-08 | Quinlan Amy | Other | 28.50K | $3.68 | 104.88K |
| 2026-04-02 | Sandrock Alfred | Sell | 11.51K | $3.87 | 44.55K |
| 2026-04-01 | Shiferman Gregory L. | Buy | 50.00K | — | — |
| 2026-02-24 | Swartz Robin | Sell | 6.46K | $3.77 | 24.35K |
| 2026-02-24 | Sandrock Alfred | Sell | 14.20K | $3.79 | 53.81K |
| 2026-02-24 | Jorgensen Nathan D. | Sell | 4.67K | $3.77 | 17.60K |
| 2026-02-24 | Carter Todd Alfred | Sell | 4.17K | $3.76 | 15.69K |
| 2026-02-18 | Swartz Robin | Sell | 3.88K | $3.44 | 13.35K |
| 2026-02-18 | Carter Todd Alfred | Sell | 3.30K | $3.44 | 11.36K |
| 2026-02-18 | Sandrock Alfred | Sell | 11.73K | $3.41 | 40.01K |
| 2026-02-10 | Swartz Robin | Sell | 4.57K | $3.85 | 17.59K |
| 2026-02-10 | Sandrock Alfred | Sell | 12.19K | $3.78 | 46.09K |
| 2026-02-10 | Carter Todd Alfred | Sell | 3.52K | $3.85 | 13.57K |
| 2026-02-06 | Ferguson Toby | Buy | 210.00K | $3.68 | 772.80K |
| 2026-02-06 | Ferguson Toby | Buy | 45.00K | — | — |
| 2026-02-06 | Carter Todd Alfred | Buy | 33.00K | — | — |
| 2026-02-06 | Carter Todd Alfred | Buy | 154.00K | $3.68 | 566.72K |
| 2026-02-06 | Swartz Robin | Buy | 45.00K | — | — |
| 2026-02-06 | Swartz Robin | Buy | 210.00K | $3.68 | 772.80K |
| 2026-02-06 | Sandrock Alfred | Buy | 86.25K | — | — |
| 2026-02-06 | Sandrock Alfred | Buy | 402.50K | $3.68 | 1.48M |
| 2026-02-06 | Jorgensen Nathan D. | Buy | 32.25K | — | — |
| 2026-02-06 | Jorgensen Nathan D. | Buy | 150.50K | $3.68 | 553.84K |
| 2026-01-06 | Shiferman Gregory L. | Buy | 100.00K | $4.02 | 402.00K |
| 2026-01-06 | Shiferman Gregory L. | Other | 0 | — | — |
| 2025-10-03 | Jorgensen Nathan D. | Sell | 7.67K | $4.78 | 36.64K |
| 2025-08-18 | Ferguson Toby | Sell | 19.00K | $3.73 | 70.87K |
| 2025-06-03 | Vitale Nancy | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | SCANGOS GEORGE A | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | PIERCE GLENN | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | Onyia Jude | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | MACKEY CATHERINE J | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | Hyman Steven | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | Higgins Michael J | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | GERAGHTY JAMES A | Buy | 24.00K | $3.28 | 78.72K |
| 2025-06-03 | Colon Grace | Buy | 24.00K | $3.28 | 78.72K |
| 2025-04-02 | Ferguson Toby | Sell | 10.09K | $3.43 | 34.59K |
| 2025-04-02 | Sandrock Alfred | Sell | 10.88K | $3.43 | 37.34K |
| 2025-02-21 | Carter Todd Alfred | Buy | 46.00K | — | — |
| 2025-02-21 | Carter Todd Alfred | Buy | 92.00K | $4.22 | 388.24K |
| 2025-02-21 | Sandrock Alfred | Buy | 145.00K | — | — |
| 2025-02-21 | Sandrock Alfred | Buy | 290.00K | $4.22 | 1.22M |
| 2025-02-21 | Swartz Robin | Buy | 71.25K | — | — |
| 2025-02-21 | Swartz Robin | Buy | 142.50K | $4.22 | 601.35K |
| 2025-02-21 | Fahey Sandell Jacquelyn | Buy | 41.50K | — | — |
| 2025-02-21 | Fahey Sandell Jacquelyn | Buy | 83.00K | $4.22 | 350.26K |
| 2025-02-21 | Ferguson Toby | Buy | 63.00K | — | — |
| 2025-02-21 | Ferguson Toby | Buy | 126.00K | $4.22 | 531.72K |
| 2025-02-21 | Jorgensen Nathan D. | Buy | 51.50K | — | — |
| 2025-02-21 | Jorgensen Nathan D. | Buy | 103.00K | $4.22 | 434.66K |
| 2025-02-20 | Carter Todd Alfred | Sell | 3.31K | $4.26 | 14.08K |
| 2025-02-20 | Sandrock Alfred | Sell | 11.70K | $4.24 | 49.62K |
| 2025-02-20 | Swartz Robin | Sell | 3.89K | $4.25 | 16.55K |
| 2025-02-11 | Carter Todd Alfred | Sell | 5.41K | $4.45 | 24.09K |
| 2025-02-11 | Swartz Robin | Sell | 6.95K | $4.45 | 30.93K |
| 2025-02-11 | Sandrock Alfred | Sell | 16.64K | $4.45 | 74.07K |
| 2025-02-11 | Fahey Sandell Jacquelyn | Sell | 4.36K | $4.45 | 19.39K |
| 2025-01-14 | Swartz Robin | Sell | 3.09K | $5.09 | 15.71K |
| 2025-01-14 | Carter Todd Alfred | Sell | 1.19K | $5.13 | 6.11K |
| 2024-12-23 | Swartz Robin | Sell | 6.50K | $5.65 | 36.73K |
| 2024-10-02 | Fahey Sandell Jacquelyn | Sell | 6.00K | $5.82 | 34.91K |
| 2024-10-01 | Jorgensen Nathan D. | Buy | 80.00K | — | — |
| 2024-07-08 | Jorgensen Nathan D. | Buy | 200.00K | $7.79 | 1.56M |
| 2024-07-08 | Jorgensen Nathan D. | Other | 0 | — | — |
| 2024-06-05 | Vitale Nancy | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | SCANGOS GEORGE A | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | PIERCE GLENN | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | Onyia Jude | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | MACKEY CATHERINE J | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | Hyman Steven | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | Higgins Michael J | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | GERAGHTY JAMES A | Buy | 24.00K | $8.70 | 208.80K |
| 2024-06-05 | Colon Grace | Buy | 24.00K | $8.70 | 208.80K |
| 2024-04-02 | Swartz Robin | Sell | 1.36K | $9.88 | 13.41K |
| 2024-04-02 | Sandrock Alfred | Sell | 12.12K | $9.86 | 119.45K |
| 2024-04-01 | Ferguson Toby | Buy | 105.00K | — | — |
| 2024-03-25 | Ferguson Toby | Buy | 210.00K | $9.26 | 1.94M |
| 2024-03-25 | Ferguson Toby | Other | 0 | — | — |
| 2024-02-21 | Swartz Robin | Sell | 3.97K | $7.45 | 29.55K |
| 2024-02-21 | Sandrock Alfred | Sell | 13.03K | $7.46 | 97.23K |
| 2024-02-21 | PFREUNDSCHUH PETER P. | Sell | 3.76K | $7.46 | 28.08K |
| 2024-02-21 | Carter Todd Alfred | Sell | 3.37K | $7.47 | 25.14K |
| 2024-02-20 | Carter Todd Alfred | Sell | 602 | $7.68 | 4.62K |
| 2024-02-09 | Fahey Sandell Jacquelyn | Buy | 31.00K | — | — |
| 2024-02-09 | Fahey Sandell Jacquelyn | Buy | 62.00K | $7.60 | 471.20K |
| 2024-02-09 | Carter Todd Alfred | Buy | 38.50K | — | — |
| 2024-02-09 | Carter Todd Alfred | Buy | 77.00K | $7.60 | 585.20K |
| 2024-02-09 | Swartz Robin | Buy | 50.00K | — | — |
| 2024-02-09 | Swartz Robin | Buy | 100.00K | $7.60 | 760.00K |
Latest filed quarter: Q2 2026.
Institutions holding: 144, holders +5 vs prior quarter. Ownership 58.15%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 5.17M | -396.32K | -7.12% | 18.10M |
| MILLENNIUM MANAGEMENT LLC | 4.44M | 1.01M | +29.59% | 15.55M |
| ARMISTICE CAPITAL, LLC | 3.44M | -64.00K | -1.83% | 12.03M |
| VESTAL POINT CAPITAL, LP | 2.62M | -377.94K | -12.59% | 9.19M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.35M | 62.42K | +2.73% | 8.21M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.33M | 280.51K | +26.72% | 4.66M |
| OPALEYE MANAGEMENT INC. | 1.19M | 35.00K | +3.04% | 4.15M |
| STATE STREET CORP | 1.08M | 128.20K | +13.52% | 3.77M |
| TWO SIGMA INVESTMENTS, LP | 948.52K | 332.86K | +54.07% | 3.32M |
| DIMENSIONAL FUND ADVISORS LP | 838.18K | -37.38K | -4.27% | 2.93M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 810.09K | 84.32K | +11.62% | 2.84M |
| CITADEL ADVISORS LLC | 784.07K | 770.57K | +5707.90% | 2.74M |
| MORGAN STANLEY | 697.33K | 15.62K | +2.29% | 2.44M |
| ERSTE ASSET MANAGEMENT GMBH | 638.90K | -456.24K | -41.66% | 2.29M |
| RENAISSANCE TECHNOLOGIES LLC | 495.24K | -82.79K | -14.32% | 1.73M |
| SPHERA FUNDS MANAGEMENT LTD. | 427.55K | -42.21K | -8.98% | 1.50M |
| ACADIAN ASSET MANAGEMENT LLC | 428.67K | 179.80K | +72.25% | 1.50M |
| DIADEMA PARTNERS LP | 413.64K | 263.64K | +175.76% | 1.45M |
| NORTHERN TRUST CORP | 411.80K | 26.96K | +7.01% | 1.44M |
| AQR CAPITAL MANAGEMENT LLC | 356.11K | 123.43K | +53.05% | 1.25M |
| GOLDMAN SACHS GROUP INC | 338.48K | -89.12K | -20.84% | 1.18M |
| VANGUARD FIDUCIARY TRUST CO | 337.32K | 39.00K | +13.07% | 1.18M |
| FIDUCIARY TRUST CO | 334.40K | 0 | 0.00% | 1.17M |
| JPMORGAN CHASE & CO | 276.21K | -656 | -0.24% | 988.84K |
| POINT72 ASSET MANAGEMENT, L.P. | 236.08K | -32.14K | -11.98% | 826.29K |
Voyager Therapeutics, Inc. (VYGR) trades at $1.77, with a market cap of $109.37M and a trailing P/E of -0.96. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 14220000 | 10135000 | 7619000 | 104391000 | 171128000 | 37415000 | 40907000 | 250008000 | 80001000 | 40374000 |
Insights · Dividends · Forecast · Financials · Learn
$109.37M
Market Cap
-0.96
P/E
—
Forward P/E
46
Score